CFO Steven Cook Sells Shares of Omada Health, Inc.
Steven Cook, CFO of Omada Health, sold 33,000 shares in a planned transaction.
Key Points
- CFO Steven Cook sold 33,000 shares of Omada Health on June 26, 2026, in a planned sale at an average price of $19.89, totaling $656,370.
- Omada Health, Inc., traded at $21.95 on Wednesday, has a market cap of $1.24 billion and a forward P/E of 43.84.
- Morgan Stanley reiterated a buy rating for Omada with a $30 target on June 22, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 26, 2026, Steven Cook, the Chief Financial Officer of Omada Health, Inc. (NasdaqGS: OMDA), sold 33,000 shares of the company. The shares were sold at an average price of $19.89 each, totaling $656,370. This transaction was part of a planned sale.
Insider Buying and Selling at Omada Health, Inc.
Steven Cook, Omada Health's CFO, has been active in the stock market recently. On June 29, 2026, he sold an additional 17,950 shares at $21.07 each. Other insiders, including Craig Gracey, Chief Accounting Officer, and Sean Duffy, CEO, also executed planned sales on June 26 and June 29.
Omada Health, Inc. Stock Down 10.6%
Shares of Omada Health traded near $21.95 on Wednesday. The company has a market capitalization of approximately $1.24 billion and a forward P/E ratio of 43.84. Over the past year, the stock has ranged from a low of $10.28 to a high of $26.92. Its 50-day moving average is $16.45, and the 200-day moving average is $17.13. Omada Health maintains a strong financial position with a current ratio of 3.92 and a quick ratio of 3.69.
$OMDA stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On June 22, 2026, Morgan Stanley reiterated its buy rating for Omada Health, setting a price target of $30. Several other firms, including Barclays and Goldman Sachs, have maintained their buy ratings with targets ranging from $20 to $23. The consensus target price among 12 analysts is approximately $22.92.
About Omada Health
Omada Health, Inc., based in South San Francisco, California, operates in the healthcare sector, specifically in health information services. The company provides a variety of virtual care programs in the United States, including those for cardiometabolic conditions, musculoskeletal health, and weight management. Omada Health offers its services to employers, health plans, and pharmacy benefits managers through direct sales and channel partners. Led by CEO Sean P. Duffy, the company employs around 943 people.
Bottom Line
Steven Cook's recent planned sale of shares in Omada Health highlights ongoing insider activity. Investors follow these transactions closely, as they can provide insights into company leadership's confidence levels. It's important to remember that these transactions are reported after the fact and might not reflect current insider sentiment. As always, these insights are just one piece of the broader investment puzzle.
Get Omada Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $OMDA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.